Tongji Hospital
Tongji Hospital
Wuhan, Hubei, China25 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPD | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Not yet recruiting | Not applicable | 2026-06-24 | NCT07665359 | |
| Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer | Advanced Biliary Tract Carcinoma | Recruiting | Phase 1 / Phase 2 | 2026-03-23 | NCT07392541 | |
| The Chinese Familial Alzheimer's Network | Alzheimer disease, Familial Alzheimer Disease (FAD), brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Not stated | 2026-03-23 | NCT03657732 | |
| China Cognition and Aging Study | Alzheimer Disease, Late Onset, Alzheimer disease, Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, Familial Alzheimer Disease (FAD), Leukoencephalopathies, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-03-23 | NCT03653156 | |
| Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification | Solid Tumors | Not yet recruiting | Phase 2 | 2026-02-18 | NCT07417501 | |
| AI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study) | Colorectal Cancer Liver Metastases (CRLM) | Recruiting | Not stated | 2026-02-10 | NCT07399236 | |
| Prospective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer | Colorectal Cancer Liver Metastasis | Recruiting | Not stated | 2026-02-06 | NCT07392567 | |
| ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 | 2026-01-08 | NCT07327034 | |
| A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients | Metastatic Castration-resistant Prostate Cancer | Recruiting | Phase 1 / Phase 2 | 2025-12-22 | NCT06155084 | |
| Effectiveness of an Edge AI-based Augmented Reality System for Hand Hygiene Training: a Multi-centre, Mixed-methods Cluster Randomised Controlled Trial | Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, iatrogenic disease, nosocomial infection | Recruiting | Not applicable | 2025-12-12 | NCT07280026 | |
| A Study of YL202 in Selected Patients With Advanced Solid Tumors | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, non-small cell lung carcinoma, skin disorder, squamous cell carcinoma | Recruiting | Phase 2 | 2025-11-26 | NCT06107686 | |
| To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Recruiting | Not stated | 2025-09-02 | NCT07149571 | |
| Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Phase 3 | 2025-06-24 | NCT06954584 | |
| To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors | 19 and 20+ B Cell Hematologic Tumors; 19 and 22+ B Cell Hematologic Tumors | Recruiting | Phase 1 | 2025-06-18 | NCT05388695 | |
| A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence | hepatocellular carcinoma | Active, not recruiting | Not applicable | 2025-06-06 | NCT07009470 | |
| Efficacy and Safety of Fospropofol in Adult Laparoscopic Surgery: A Clinical Trial | Drug Safety | Recruiting | Phase 4 | 2025-04-16 | NCT06573489 | |
| A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Early phase 1 | 2025-03-17 | NCT06849609 | |
| A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Not yet recruiting | Phase 3 | 2025-01-10 | NCT06767540 | |
| Oliceridine-Enhanced Analgesia and Recovery: A G-Protein Biased μ-Opioid Study | Postoperative Analgesia | Recruiting | Not applicable | 2025-01-03 | NCT06409689 | |
| Opioid-Free Combined Anesthesia With Spontaneous Breathing for VATS | Video-assisted Thoracoscopic Lung Surgery；Anesthesia | Recruiting | Not applicable | 2025-01-03 | NCT06367218 | |
| Recurrent High Grade Glioma Treated by LITT | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Not applicable | 2024-11-29 | NCT06161610 | |
| The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM). | Type1 Diabetes Mellitus | Not yet recruiting | Not stated | 2024-09-23 | NCT06606509 | |
| A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not stated | 2024-07-29 | NCT06525909 | |
| To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2 | High-risk Non-muscle Invasive Bladder Cancer | Recruiting | Phase 1 / Phase 2 | 2024-07-11 | NCT06378242 | |
| Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma | Recruiting | Phase 1 | 2024-06-24 | NCT06470256 |